Our team of pediatric oncologists and hematologists come from diverse professional and academic backgrounds. We work closely with your family to ensure your child receives the best care.
Learn more about our physicians and feel confident about your choices of pediatric oncology and hematology experts.
Dr. Goldenberg was named director of research at Johns Hopkins All Children's Hospital in July 2012 as well as chief research officer of the All Children's Research Institute and director of the new Clinical and Translational Research Organization at JHACH. He is an associate professor of pediatrics and medicine at the Johns Hopkins University School of Medicine.
Dr. Goldenberg is principal investigator for both the iPICS (Institution-wide Prospective Inception Cohort Study of Individuals with Childhood-Onset Acute and Chronic Health Conditions) and PREDICT (Prospective Research on Early Determinants of Illness and Children's Health Trajectories) studies at JHACH. Both studies unite physician-scientists in St. Petersburg and Baltimore in searching for biomarkers to improve the diagnosis and treatment of serious diseases and gain insights about the role of genetic, epigenetic and environmental factors that influence development of disease.
He is the principal investigator, steering committee chair or data and safety monitoring committee chair for several NIH- and industry-sponsored multicenter clinical trials, and has co-authored international clinical and clinical research guidelines.
Dr. Goldenberg is director of the pediatric thrombosis program at JHACH and is co-director of the pediatric stroke program. He also leads the Prospective Multicenter Evaluation of the Duration of Therapy for Thrombosis in Children (known as KIDS-DOTT), a study that involves more than two dozen medical institutions.
Dr. Metts specializes in pediatric hematology/oncology in the Johns Hopkins All Children's Cancer & Blood Disorders Institute. He joined the hospital in 2016.
He received his medical degree from the University of South Carolina School of Medicine and completed an internship and residency in pediatrics at Johns Hopkins All Children’s Hospital through the University of South Florida Morsani School of Medicine.
Dr. Metts then trained at Emory University School of Medicine as a pediatric hematology/oncology fellow.
Dr. Oshrine specializes in blood and marrow transplants as a pediatric hematologist/oncologist in the Johns Hopkins All Children’s Cancer & Bone Marrow Disorders Institute. His clinical focus is in the treatment of high-risk leukemias with blood and marrow transplantation, and his research focus is in immune recovery after transplant. He joined the hospital in 2014 after completing a fellowship in pediatric hematology/oncology at the Children’s Hospital of Philadelphia.
Dr. Oshrine earned his medical degree from the University of Virginia School of Medicine and completed his residency at Boston Children’s Hospital.
He is certified by the American Board of Pediatrics and a member of the American Society of Pediatric Hematology/Oncology, the Children’s Oncology Group, the American Society of Blood and Marrow Transplantation and the American Society of Clinical Oncology.
Dr. Reed specializes in sarcomas in the Johns Hopkins All Children’s Cancer & Blood Disorders Institute. He joined the hospital in 2008.
He also is director of the Adolescent and Young Adult (AYA) Program at H. Lee Moffitt Cancer Center, which collaborates with the Johns Hopkins All Children’s AYA Program. He is the medical director of the sarcoma program at Moffitt. He leads the National Pediatric Cancer Foundation’s Sunshine Project, a pediatric phase I research consortium with active trials accruing patients across the country and other trials being developed. He also runs an active lab with support from the National Pediatric Cancer Foundation (nationalpcf.org), the V Foundation, and other community supports.
Dr. Reed earned his medical degree from Case Western Reserve University School of Medicine in Cleveland, Ohio. He completed a pediatric residency program at Boston Children’s Hospital and a pediatric hematology/oncology fellowship at St. Jude’s Children’s Hospital.
Dr. Shaw joined the Johns Hopkins All Children’s Cancer & Blood Disorders Institute in August 2016 as deputy director and currently also serves as the institute’s interim director. He works collaboratively with the entire hematology-oncology team and other pediatric specialists at Johns Hopkins All Children’s Hospital to provide comprehensive care throughout each patient’s cancer journey and provide the best outcomes for children, teens and young adults with cancer.
Dr. Shaw is recognized nationally as a leader in the areas of adolescent and young oncology (AYA). He is founding member of the Consortium of Adolescent and Young Adult Cancer Centers and helped develop internally recognized standards for care of this population.
Dr. Shaw previously was clinical director of oncology and director of the hematology/oncology clinic at the institute from Children’s Hospital of Pittsburgh, where he established one of the nation’s first AYA programs, providing care for teens ages 15 to 22. He has presented at national and international oncology meetings, authored numerous papers and case reports published in peer-reviewed journals, and is an associate editor of the Journal of Pediatric Hematology/Oncology.
Dr. Stapleton is the director of pediatric neuro-oncology at Johns Hopkins All Children’s Hospital. Dr. Stapleton joined the hospital in 2007 and is double-board certified by the American Board of Pediatrics in general pediatrics and pediatric hematology/oncology. She has formal training in pediatric neuro-oncology.
Dr. Stapleton is on the Pediatric Palliative Care Team at Johns Hopkins All Children’s and she specializes in symptom control and end of life care. She has been awarded a $247,000 grant for clinical research in pediatric palliative care and nearly $350,000 in grant funds for her work in phase I studies for patients with brain and spinal cord tumors. Dr. Stapleton’s research experience includes investigator-initiated and multi-center research projects.
Dr. Stapleton is an associate professor of pediatrics at the University of South Florida and an assistant professor in the department of pediatrics at Johns Hopkins University.
Dr. Stapleton completed her medical training at St. Louis University School of Medicine, residency training at Lackland Air Force Base in Texas and fellowship training at Baylor College of Medicine/Texas Children’s Hospital. Dr. Stapleton also served 13 years in the United States Air Force. Dr. Stapleton is a member of the American Board of Pediatrics, the Children’s Oncology Group, the Society of Neuro-Oncology, American Society of Pediatric Hematology/Oncology, and America Academy of Hospice and Palliative Medicine.
Dr. Sunkersett specializes in pediatric hematology, oncology and bone marrow transplantation in the Johns Hopkins All Children’s Cancer & Blood Disorders Institute. Her areas of clinical focus and interest include stem cell transplantation, graft-versus-host disease, immunotherapy, T-cell regulation, high-risk leukemia, primary immunodeficiencies, gut microbiota and biomarkers. She has been published in leading journals in her field and invited to national conferences to present her research.
Dr. Sunkersett joined Johns Hopkins All Children’s in 2017 after completing a clinical fellowship in pediatric hematology/oncology at Children’s Medical Center at the University of Texas Southwestern in Dallas and a subspecialized clinical fellowship in pediatric bone marrow transplantation at the University of California, San Francisco Benioff Children’s Hospital.